BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 2
• 3
• 4
• 5
• 7
• 8
• 9
• 10
• 11
• 12
• 14
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30

• 

  Opinion

  Local trade groups must support life sciences in these difficult times

  As the industry faces policy changes and significant cuts to federal funding, local ecosystems can bolster companies through innovative resources to sustain growth and keep the U.S. at the center of biomedical innovation.

  June 10, 2026

   · 

  4 min read

   · 

  Jennifer Hawks Bland
• 

  IPO

  Update: Parabilis raises industry-record $670M IPO

  Parabilis Medicines is joining the parade of biotechs going public, with one key difference—more money.

  June 10, 2026

   · 

  2 min read

   · 

  Gabrielle Masson
• 

  China

  New biotech group rises to fuel American rockets in China ‘space race’

  Members of the American Biotech Innovation Alliance (ABIA) want to build a national biotech strategy—just like China did years ago.

  June 10, 2026

   · 

  3 min read

   · 

  Annalee Armstrong
• Press Releases

  New Polymorph of Indomethacin Discovered

  June 10, 2026

   · 

  3 min read
• Press Releases

  Element Biosciences Announces Upsized Series E to Accelerate Global Growth Across Ecosystem of Genomic, Multiomic, and Clinical Research Solutions

  June 10, 2026

   · 

  3 min read
• Press Releases

  Nucala (mepolizumab) approved in Canada for use in adults with chronic obstructive pulmonary disease (COPD)

  June 10, 2026

   · 

  8 min read
• Press Releases

  AB Science is invited to present at the 2026 ENCALS annual meeting the survival data from masitinib clinical program in ALS

  June 10, 2026

   · 

  5 min read
• Press Releases

  Albert Einstein College of Medicine Launches BIO-VITAL to Accelerate Gerotherapeutics

  June 10, 2026

   · 

  4 min read
• Press Releases

  Critical Path Institute to Convene Drug Development Leaders at 2026 Global Impact Conference

  June 10, 2026

   · 

  4 min read
• 

  Mergers & acquisitions

  Lilly’s $25B+ M&A spree captures half of pharma’s 2026 capacity

  Over the past decade, Eli Lilly has bought out more biotechs than any of the other top 12 pharmas by revenue—with 10 of those acquisitions arriving just this year.

  June 10, 2026

   · 

  1 min read

   · 

  Annalee Armstrong